{"SPADE_UN_13006": {"Clinical Information": [], "Patent Information": [{"Patent No": "US 2020/0115426 A1", "Patent Link": "http://www.lens.org/lens/patent/US_2020_0115426_A1", "Patent Type": "Patent Application", "Publication Date": "2020-4-16", "Family Info": "EP3323827A1,WO2018091523A1,EP3541831A1", "Patent Title": "Cationic Intrinsically Disordered Antimicrobial Peptides", "Abstract": "The present invention generally relates to the field of antimicrobial peptides (AMPs), and more specifically to cationic intrinsically disordered antimicrobial peptides (CIDAMPs) and their use as disinfectants and therapeutic agents for the treatment of infections, especially as a therapeutic alternative for the treatment of infectious diseases caused by antibiotic resistant microorganisms."}], "Sequence Information": {"SPADE ID": "SPADE_UN_13006", "Sequence": "RGSGSGHQGHSSSHGLGSGHRG", "Sequence Length": 22, "Peptide Name": "Sequence 122 from Patent US 20200115426", "Source": "Synthetic construct", "Biological Activity": ["Antimicrobial", "Antibacterial"], "Frequent Amino Acids": "GSH", "Absent Amino Acids": "ACDEFIKMNOPTUVWY", "Basic Residues": 6, "Acidic Residues": 0, "Hydrophobic Residues": 1, "Polar Residues": 13, "Positive Residues": 6, "Negative Residues": 0, "Mass": 2099.1, "PI": 12.0, "Net Charge": 6, "Hydrophobicity": -1.34, "Similar Sequences": [{"SPADE_ID": "SPADE_UN_13504", "Similarity": 0.8333333333333334, "Sequence": "SLDQINVTFLDLEYEMKKLEEAIKKLEESYIDLKELGSGSG"}, {"SPADE_ID": "SPADE_UN_23087", "Similarity": 0.8333333333333334, "Sequence": "DISGINASVVNIQKEIDRLNEVAKNLNESLIDLQELGSGSG"}, {"SPADE_ID": "SPADE_UN_23130", "Similarity": 0.8333333333333334, "Sequence": "SLTQINTTLLDLTYEMLSLQQVVKALNESYIDLKELGSGSG"}]}}}